Buy Deus Medical TRESTOLONE E 100 (Trestolone Enanthate) – Deus Medical
Deus Medical TRESTOLONE E 100 (Trestolone Enanthate) by Deus Medical is a laboratory-verified research compound supplied for scientific investigation. Every lot is analytically tested prior to release, with certificates of analysis available on request. Domestic USA shipping within 24 to 48 business hours.
Product Specifications
- Product: Deus Medical TRESTOLONE E 100 (Trestolone Enanthate)
- Brand: Deus Medical
- Category: Injectable Steroids
- Active Substance: Trestolone Enanthate
- Origin: Manufactured in accordance with brand quality standards
About This Compound
TRESTOLONE E 100 (TRESTOLONE ENANTHATE) – Long-Ester Injectable for Advanced Users
PRODUCT OVERVIEW
Trestolone Enanthate is an injectable option aimed at advanced individuals who already feel comfortable working with very strong compounds inside tightly planned cycles that follow a fixed struc..
Quality Assurance
Deus Medical products distributed through NAPS Peptides are subject to independent verification. Every incoming batch is inspected and lot-traced. Certificates of Analysis are available on request for any product in this catalog.
Shipping and Fulfillment
All orders placed before 2:00 PM Eastern time typically ship the same business day. Orders after that time ship the following business day. We ship exclusively within the United States via USPS Priority Mail and UPS Ground. Packaging is plain, unmarked, and includes a tracking number.
Research Use Only Disclaimer
Deus Medical TRESTOLONE E 100 (Trestolone Enanthate) sold by NAPS Peptides is intended strictly for laboratory research purposes. It is not a drug, food, cosmetic, dietary supplement, or medical device. It is not intended for human or animal consumption, in vitro diagnostic use, or clinical application. By purchasing this product, you affirm that you are a qualified researcher aged 21 or older and that you accept full responsibility for the safe and legal handling of the compound.
Reviews
There are no reviews yet.